Literature DB >> 2562846

Restricted tissue distribution of Mlsa determinants. Stimulation of Mlsa-reactive T cells by B cells but not by dendritic cells or macrophages.

S R Webb1, A Okamoto, Y Ron, J Sprent.   

Abstract

Evidence was sought on the tissue distribution of Mlsa determinants, a class of cell-associated non-H-2 alloantigens that is highly immunogenic for unprimed T cells. Whereas normal CD4+ T cells and an Mlsa-reactive T hybridoma gave strong responses to Mlsa-positive stimulator populations containing Ig+ B cells, anti-Mlsa responses to B-depleted stimulators were almost undetectable. The B-depleted stimulators tested included Thy-1- spleen cells from mu-suppressed mice (mice treated with anti-mu antibody from birth) and J11d- preparations of spleen dendritic cells (DC) and peritoneal macrophages (M phi) from normal mice. Each of these populations was strongly immunogenic for allo-H-2-reactive T cells. The failure to detect Mlsa determinants on Ig- APC, i.e., M phi and DC, suggests that Mlsa determinants are not typical H-2-associated peptides. The data are more compatible with a model in which Mlsa determinants represent (or form part of) an integral cell membrane molecule expressed largely, and perhaps exclusively, on B cells. T cells might recognize these molecules only in native form, "processed" Mlsa determinants being nonimmunogenic. Consistent with this possibility, no evidence was found that Mlsa-negative B cells could absorb Mlsa determinants from Mlsa-positive B cells in a chimeric environment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562846      PMCID: PMC2189198          DOI: 10.1084/jem.169.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  The immunobiology of T cell responses to Mls-locus-disparate stimulator cells. II. Effects of Mls-locus-disparate stimulator cells on cloned, protein antigen-specific, Ia-restricted T cell lines.

Authors:  M E Katz; C A Janeway
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants.

Authors:  S R Webb; A Okamoto; J Sprent
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

3.  T cells can distinguish between allogeneic major histocompatibility complex products on different cell types.

Authors:  P Marrack; J Kappler
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

4.  Specific neonatally induced tolerance to Mls locus determinants.

Authors:  S Macphail; S T Ishizaka; M J Bykowsky; E C Lattime; O Stutman
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

5.  Restricted recognition of beta 2-microglobulin by cytotoxic T lymphocytes.

Authors:  H G Rammensee; P J Robinson; A Crisanti; M J Bevan
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

6.  Antigen-presenting cells for Lyt-2+ cells. I. Stimulation of unprimed Lyt-2+ cells by H-2 different Thy-1-Ia- cells prepared from spleen and bone marrow.

Authors:  J Sprent; M Schaefer
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

7.  Downregulation of T cell responses by antibodies to the T cell receptor.

Authors:  S Webb; J Sprent
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

8.  Mls is not a single gene, allelic system. Different stimulatory Mls determinants are the products of at least two nonallelic, unlinked genes.

Authors:  R Abe; J J Ryan; R J Hodes
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

9.  Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow.

Authors:  R Korngold; J Sprent
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.

Authors:  J Sprent; M Schaefer
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  19 in total

1.  A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection.

Authors:  S Vacheron; T Renno; H Acha-Orbea
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  The stage of negative selection in tolerance induction in neonatal mice.

Authors:  T Ando; Y Yoshikai; G Matsuzaki; H Takimoto; K Nomoto
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  Clonal deletion of self-Mls-reactive thymocytes at the early stage in H-2-compatible but Mls-disparate radiation chimeras.

Authors:  M Ogimoto; Y Yoshikai; G Matsuzaki; S Ohga; K Matsumoto; K Nomoto
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

4.  In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.

Authors:  C Krummenacher; H Diggelmann; H Acha-Orbea
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  T-cell tolerance induced in nude mice grafted with thymic epithelium.

Authors:  J H Robinson; C J Chapman; B E Loveland; R K Jordan
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

6.  Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival.

Authors:  Steven R Duncan; Nickolas G Capetanakis; Brian R Lawson; Argyrios N Theofilopoulos
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

7.  Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.

Authors:  L H Nguyen; D M Knipe; R W Finberg
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Genetic studies on experimental autoimmune gastritis induced by neonatal thymectomy using recombinant inbred strains between a high-incidence strain, BALB/c, and a low-incidence strain, DBA/2.

Authors:  Y Mori; M Hosono; K Murakami; H Katoh; Y Yoshikawa; K Kuribayashi; R Kannagi; M Sakai; M Okuma; T Masuda
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

9.  Production and characterization of an Mls-1-specific monoclonal antibody.

Authors:  N Mohan; D Mottershead; M Subramanyam; U Beutner; B T Huber
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

10.  The primary in vivo immune response to Mls-1 (Mtv-7 sag). Route of injection determines the immune response pattern.

Authors:  M Andersson; H Acha-Orbea
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.